![The Impact of CHA2DS2-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet Study - ScienceDirect The Impact of CHA2DS2-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936879820312875-fx1.jpg)
The Impact of CHA2DS2-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet Study - ScienceDirect
![CHADS2 and CHA2DS2-VASc score for stroke risk and HAS-BLED score for bleeding risk on oral anticoagulation in atrial fibrillation (AF) - eDucate Health CHADS2 and CHA2DS2-VASc score for stroke risk and HAS-BLED score for bleeding risk on oral anticoagulation in atrial fibrillation (AF) - eDucate Health](https://www.educateyourhealth.com/wp-content/uploads/2020/06/CHADS2-and-CHA2DS2-VASc-score-for-stroke-risk-and-HAS-BLED-score-for-bleeding-risk-on-oral-anticoagulation-in-atrial-fibrillation.jpg)
CHADS2 and CHA2DS2-VASc score for stroke risk and HAS-BLED score for bleeding risk on oral anticoagulation in atrial fibrillation (AF) - eDucate Health
![Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study - The American Journal of Medicine Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study - The American Journal of Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e5614117-2a0c-4b75-ad37-f90eb5c67e93/gr1_lrg.jpg)
Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study - The American Journal of Medicine
![Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk](https://www.ahajournals.org/cms/asset/f0c76a4b-279a-46cf-abea-39dfbbb036a3/e003476fig02.jpeg)
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk
![Debbe McCall on Twitter: "This new study suggests that older patients with #AFib are at high risk of thromboembolic events regardless of #CHA2DS2 -VASc score. #stroke https://t.co/BopLIb1m41 https://t.co/5yxRSkIygf" / Twitter Debbe McCall on Twitter: "This new study suggests that older patients with #AFib are at high risk of thromboembolic events regardless of #CHA2DS2 -VASc score. #stroke https://t.co/BopLIb1m41 https://t.co/5yxRSkIygf" / Twitter](https://pbs.twimg.com/media/EKPmxkLXYAAxc6A.jpg)
Debbe McCall on Twitter: "This new study suggests that older patients with #AFib are at high risk of thromboembolic events regardless of #CHA2DS2 -VASc score. #stroke https://t.co/BopLIb1m41 https://t.co/5yxRSkIygf" / Twitter
![Association between modified CHA2DS2-VASc Score with Ankle-Brachial index < 0.9 | Scientific Reports Association between modified CHA2DS2-VASc Score with Ankle-Brachial index < 0.9 | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-018-19243-y/MediaObjects/41598_2018_19243_Fig1_HTML.jpg)
Association between modified CHA2DS2-VASc Score with Ankle-Brachial index < 0.9 | Scientific Reports
![Using CHADS2 and CHA2DS2-VASc scores for mortality prediction in patients with chronic kidney disease | Scientific Reports Using CHADS2 and CHA2DS2-VASc scores for mortality prediction in patients with chronic kidney disease | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-76098-y/MediaObjects/41598_2020_76098_Fig1_HTML.png)
Using CHADS2 and CHA2DS2-VASc scores for mortality prediction in patients with chronic kidney disease | Scientific Reports
![CHA2DS2-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation - Mayo Clinic Proceedings CHA2DS2-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation - Mayo Clinic Proceedings](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b6a25ca1-cff2-4cb5-94c0-145fe1a009b7/gr1.jpg)
CHA2DS2-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation - Mayo Clinic Proceedings
![Usefulness of the CHA2DS2-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - American Journal of Cardiology Usefulness of the CHA2DS2-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/de638cd8-e034-42f9-97aa-3656fac301fb/gr1.jpg)
Usefulness of the CHA2DS2-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - American Journal of Cardiology
![CHA2DS2-VASc scores and Intermountain Mortality Risk Scores for the joint risk stratification of dementia among patients with atrial fibrillation - ScienceDirect CHA2DS2-VASc scores and Intermountain Mortality Risk Scores for the joint risk stratification of dementia among patients with atrial fibrillation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1547527118310452-fx1.jpg)
CHA2DS2-VASc scores and Intermountain Mortality Risk Scores for the joint risk stratification of dementia among patients with atrial fibrillation - ScienceDirect
![Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem? Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?](https://www.escardio.org/static-file/Escardio/Medias/councils/council-for-cardiology-practice/news/Figure%201.%20Decision%20tree%20for%20oral%20anticoagulation%20in%20patients%20with%20atrial%20fibrillation.jpg?mts=1592578501000.jpg)
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?
![Usefulness of the Addition of Renal Function to the CHA2DS2-VASc Score as a Predictor of Thromboembolism and Mortality in Patients Without Atrial Fibrillation - American Journal of Cardiology Usefulness of the Addition of Renal Function to the CHA2DS2-VASc Score as a Predictor of Thromboembolism and Mortality in Patients Without Atrial Fibrillation - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/331b7ff5-b3ed-4812-b837-8dc60da56b5f/gr1_lrg.jpg)